NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

MetLife, Inc. MET | NYSE

$97.75 $0.00 | 0.00%

Next Earnings: Sep 14, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
FWD PE *: 9.3x
Payout Ratio (TTM): 46.4%
52-Week Range: $67.33 - $100.93

* Forward PE is based on street estimates.

10 Year MET Performance Metrics:

Total Return (with DRIP): 249.0% (13.31% CAGR)
Total Return (no DRIP): 199.6% (11.60% CAGR)
Share Price: 150.5% (9.62% CAGR)
Yield on Cost (with DRIP): 8.47%
Total Invested: $10,000
Total Value (with DRIP): $34,903
Total Return $ (with DRIP): $24,903
Dividend Increase: 66.3% (5.36% CAGR)
Dividend Yield (FWD): 2.43% ($2.37)
MET 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

MET Share Price chart

Share Price
MET Price CAGR:1Y: 21.49%2Y: 13.27%5Y: 9.97%10Y: 9.62%
MET Dividend Charts
MET - Dividends
MET Dividend CAGR:1Y: 3.52%2Y: 3.83%5Y: 4.12%10Y: 5.22%
MET - Dividend Payout Ratio
MET - Dividend to Free Cash Flow Ratio

Unlock All Reports & Research Dividend Stocks.

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)

MET Earnings, Revenue, Cash & Debt, Shares Outstanding:

MET - Revenue
MET Revenue CAGR:1Y: 9.90%2Y: 3.91%5Y: 0.38%10Y: 3.27%
MET - Earnings Per Share (EPS)
MET EPS CAGR:1Y: 4.85%2Y: -8.14%5Y: -22.88%10Y: 2.19%
MET - Net Income
🔒 Unlock
MET Net Income CAGR:1Y: 0.96%2Y: -11.79%5Y: -26.40%10Y: -2.72%
MET - EBITDA
🔒 Unlock
MET EBITDA CAGR:1Y: 6.24%2Y: -4.63%5Y: -22.38%10Y: 20.71%
MET - Free Cash Flow
🔒 Unlock
MET Free Cash Flow CAGR:1Y: 1.87%2Y: -20.10%5Y: -12.52%10Y: -3.57%
MET - Free Cash Flow / Share
🔒 Unlock
MET Free Cash Flow / Share CAGR:1Y: 4.81%2Y: -16.59%5Y: -7.51%10Y: 1.61%
MET - Operating Income
🔒 Unlock
MET Operating Income CAGR:1Y: 5.51%2Y: -7.25%5Y: -26.16%10Y: 17.74%
MET - Gross Profit
🔒 Unlock
MET Gross Profit CAGR:1Y: -38.63%2Y: -20.24%5Y: -31.54%10Y: -14.71%
MET - Shares Outstanding
🔒 Unlock
MET Shares Outstanding CAGR:1Y: -2.86%2Y: -4.22%5Y: -5.30%10Y: -5.12%
MET - Share Buybacks
🔒 Unlock
MET Share Buybacks CAGR:1Y: 41.57%2Y: -8.11%5Y: -14.85%10Y: 0.00%
MET - Stock-Based Comp
🔒 Unlock
MET Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MET - Expenses
🔒 Unlock
MET Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MET - Revenue vs Net Income
🔒 Unlock
MET - EPS vs FCF / Share
🔒 Unlock
MET - EPS vs PE Ratio
🔒 Unlock
MET - FCF vs FCF / Share
🔒 Unlock
MET - FCF vs Stock Based Comp
🔒 Unlock
MET - Cash & Debt
🔒 Unlock
MET - Revenue by Segment
🔒 Unlock
MET Revenue CAGR:1Y: 9.90%2Y: 3.91%5Y: 0.38%10Y: 3.27%
MET - Revenue by Region
🔒 Unlock
MET Revenue CAGR:1Y: 9.90%2Y: 3.91%5Y: 0.38%10Y: 3.27%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

MET - REVENUE: Actual + Estimates
🔒 Unlock
MET Actual Revenue CAGR:1Y: 9.90%2Y: 3.91%5Y: 0.38%10Y: 3.27%
MET - EPS: Actual + Estimates
🔒 Unlock
MET Actual EPS CAGR:1Y: 4.85%2Y: -8.14%5Y: -22.88%10Y: 2.19%
MET - NET INCOME: Actual + Estimates
🔒 Unlock
MET Actual Net Income CAGR:1Y: 0.96%2Y: -11.79%5Y: -26.40%10Y: -2.72%
MET - EBITDA: Actual + Estimates
🔒 Unlock
MET Actual EBITDA CAGR:1Y: 6.24%2Y: -4.63%5Y: -22.38%10Y: 20.71%

Ratios, Profit Margins & Return on Capital:

MET - Net Profit Margin
🔒 Unlock
MET Net Profit Margin CAGR:1Y: -8.02%2Y: -14.30%5Y: -26.67%10Y: -5.80%
MET - Gross Profit Margin
🔒 Unlock
MET Gross Profit Margin CAGR:1Y: -44.15%2Y: -61.58%5Y: -31.79%10Y: -17.41%
MET - Price to Earnings
🔒 Unlock
MET - Price To Sales Ratio
🔒 Unlock
MET - Return on Capital Employed
🔒 Unlock
MET - Return on Invested Capital
🔒 Unlock
Compare stocks side-by-side
 

MET Dividends Info:

Annual Dividend: $2.372
Forward Yield: 2.43%
Ex-Dividend Date: 2026-08-04
Lifetime Dividends / Share: $29.69

MET Dividend History: Dates, Payments & Yield list

Below is a schedule of all MET dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
08/04/202608/06/2026$0.5932.47%2.37%$99.95
05/12/202605/14/2026$0.5933.02%3%$79.18
02/03/202602/05/2026$0.5682.95%3.02%$75.32
11/04/202511/06/2025$0.5682.86%2.99%$75.97
08/05/202508/07/2025$0.5683.03%3.08%$73.82
05/06/202505/08/2025$0.5682.97%2.93%$77.59
02/04/202502/06/2025$0.5452.58%2.61%$83.67
11/05/202411/07/2024$0.5452.79%2.69%$81.02
08/06/202408/08/2024$0.5453.18%3.13%$69.65
05/06/202405/08/2024$0.5453.06%3.04%$71.66
02/05/202402/07/2024$0.5203.16%3.1%$67.00
11/08/202311/10/2023$0.5203.5%3.44%$60.49
08/07/202308/09/2023$0.5203.24%3.32%$62.63
05/08/202305/10/2023$0.5203.87%4.01%$51.82
02/06/202302/08/2023$0.5002.85%2.81%$71.24
11/07/202212/14/2022$0.5002.71%2.75%$72.84
08/08/202209/14/2022$0.5003.18%3.01%$66.41
05/09/202206/14/2022$0.5003.05%3.23%$61.86
02/07/202203/14/2022$0.4802.79%2.97%$64.69
11/08/202112/14/2021$0.4803.01%3.16%$60.80
08/09/202109/14/2021$0.4803.18%3.16%$60.78
05/10/202106/14/2021$0.4802.89%3.03%$63.31
02/04/202103/15/2021$0.4603.55%3.04%$60.54
11/02/202012/14/2020$0.4604.75%4.01%$45.84
08/03/202009/14/2020$0.4604.93%4.74%$38.84
05/07/202006/12/2020$0.4605.34%4.91%$37.45
02/03/202003/13/2020$0.4403.54%5.51%$31.93
11/04/201912/13/2019$0.4403.7%3.49%$50.38
08/05/201909/13/2019$0.4403.86%3.64%$48.37
05/06/201906/13/2019$0.4403.7%3.63%$48.51
02/04/201903/13/2019$0.4203.72%3.76%$44.70
11/05/201812/13/2018$0.4203.77%4.25%$39.52
08/03/201809/13/2018$0.4203.71%3.69%$45.52
05/04/201806/13/2018$0.4203.63%3.57%$47.00
02/02/201803/13/2018$0.4003.36%3.4%$47.10
11/03/201712/13/2017$0.4002.93%3.03%$52.84
08/03/201709/13/2017$0.3572.99%2.93%$48.65
05/04/201706/13/2017$0.3573.04%3%$47.51
02/02/201703/13/2017$0.3573.11%2.95%$48.27
11/03/201612/13/2016$0.3573.4%2.82%$50.53
08/04/201609/13/2016$0.3574.05%3.64%$39.19
05/05/201606/13/2016$0.3573.74%3.73%$38.24
02/03/201603/14/2016$0.3343.58%3.42%$39.13
11/04/201512/11/2015$0.3342.97%3.18%$42.00
08/05/201509/11/2015$0.3342.7%3.09%$43.25
05/07/201506/12/2015$0.3342.88%2.69%$49.71
02/04/201503/13/2015$0.3122.87%2.73%$45.77
11/05/201412/12/2014$0.3122.57%2.65%$47.08
08/06/201409/12/2014$0.3122.73%2.52%$49.44
05/07/201406/13/2014$0.3122.79%2.57%$48.55
02/04/201403/13/2014$0.2452.3%2.13%$46.11
11/06/201312/13/2013$0.2452.29%2.15%$45.62
08/07/201309/13/2013$0.2450.56%0.56%$43.52
05/07/201306/13/2013$0.2450.67%0.61%$40.03
02/04/201303/13/2013$0.1650.5%0.46%$35.63
11/07/201212/14/2012$0.6602.27%2.32%$28.38
11/07/201112/14/2011$0.6602.19%2.42%$27.21
11/05/201012/14/2010$0.6601.76%1.69%$39.00
11/05/200912/14/2009$0.6602.19%2%$32.95
11/06/200812/15/2008$0.6602.3%2.52%$26.19
11/02/200712/14/2007$0.6601.16%1.19%$55.20
11/02/200612/15/2006$0.5261.03%1%$52.34
11/03/200512/15/2005$0.4631.04%1.03%$44.88
11/03/200412/13/2004$0.4101.2%1.13%$36.19
11/05/200312/15/2003$0.2050.74%0.69%$29.59
11/06/200212/13/2002$0.1873.16%2.98%$25.10
11/02/200112/14/2001$0.1782.95%2.68%$26.57
11/03/200012/15/2000$0.1783.03%2.29%$31.19

Projected Future Returns & Dividends for MET

Based on past 10-year performance, here are MET growth metrics:

Share price CAGR of +9.62%
Dividend CAGR of +5.22%

Using MET CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, is modelled to grow as follows:

MET (DRIP)MET - No DRIP
Current Price$97.75$97.75
Start Shares102.30102.30
Start Value$10,000$10,000
  
After 10 years:
Final Share Count125.29102.30
Dividends Payment$0.99$0.99
Annual Dividends$494$404
Yield on cost4.94%4.04%
Share Price$244.88$244.88
Total Dividends$3,462$3,084
Final Value$30,681$28,135

Estimated Future Value + Dividends - MET

NOTE: Above numbers are our estimate based on MET's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)

Company Info

MetLife, Inc. (MET) had its IPO on 2000-04-05, and is trader on NYSE stock exchange.

MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.

MET website: https://www.metlife.com

Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)